The present invention relates to pharmaceutical compositions having an effect on the proliferation of NK cells, to a method for specifically stimulating the proliferation of NK cell and to the use of same in the manufacture of a drug for the antitumoral prevention, palliation, and therapy of e.g., melanoma, hepatocarcinoma or lung adenocarcinoma and for anti-microbial prevention, palliation and therapy.